
Innogen grants Arcera exclusive rights to its long-acting GLP-1 receptor agonist across Africa, Eastern Europe, Latin America and the Middle East.
Carrying the Weight of the Future
over 15 years ago
Is the 'Emerging Market' a Dated Concept?over 15 years ago
Innovation at Pfizerover 15 years ago
Mind the Gap!over 15 years ago
Giving Press Releases New Legsover 15 years ago
An IOU to Big Pharma Regarding EHRover 15 years ago
Options for Paying for Health—The Right Wayover 15 years ago
The Supremes Shape Pharmaover 15 years ago
Serbia: Ready to Flourishover 15 years ago
Employers: Fighting Non-Adherenceover 15 years ago
Europe in HTA Gridlock




